Young girls can be vaccinated against Cervical cancer with gardasil without risk of developing multiple sclerosis, according to Danish researchers.
Gardasil was in 2013 at the heart of a legal turmoil. He has been accused of being responsible for serious side effects on the central nervous system and increasing the risk of multiple sclerosis.
Following this controversy, the Academy of Medicine reacted and warned the French population. “International scientific studies” recalled the Academy of Medicine “have never demonstrated a relationship between this vaccine and a neurological demyelinating disease or any other autoimmune disease (AID)” and in France, surveillance of the vaccine has shown that ‘There is no difference in the incidence rates of the autoimmune diseases studied between the vaccinated and unvaccinated groups (2.14 per 10,000 person-years in the vaccinated, 2.06 per 10,000 person-years in unvaccinated). “
This new study confirms the position of the Academy of Medicine.
Researchers at the Statens Serum Institute in Copenhagen (Denmark) studied medical data from almost 4 million girls aged 10 to 44 to identify possible links between cervical cancer vaccination and multiple sclerosis .
The results of this study do not show any increased risk of getting this disease.
“Our study adds to the body of data supporting an overall favorable safety profile of the vaccine against HPV», Explains Nikolai Madrid Scheller, researcher in endocrinology at the Statens Serum Institute in Copenhagen. “These findings also support previous studies, such as a 2013 study that found no link between Gardasil and autoimmune diseases, neurological or venous blood clot conditions. Finally, two other studies also found no link between the autoimmune disease and Gardasil, ”the researchers conclude.
Read also:
Papillomavirus: treatment from a Japanese fungus pays off
Papillomavirus: a vaccine from 9 years old?
HPV vaccination: when to think about it?
